medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 1

<< Back Next >>

Med Int Mex 2020; 36 (1)

Hypertensive emergency of endocrinological origin: A rare disease with surgical resolution

Páez-Guerra CA, Flores-Hernández JA, Torres-López IH, Pérez-Cruz E

Language: Spanish
References: 17
Page: 118-123
PDF size: 265.73 Kb.


ABSTRACT

Background: Arterial hypertension secondary to primary hyperaldosteronism is becoming more frequent. Unilateral adrenal adenoma is a common cause of primary hyperaldosteronism, its clinical and biochemical presentation is similar to that of the aldosterone-producing adenoma.
Clinical case: A 59-year-old male patient who attended to the emergency room due to sudden diminishment of muscle strength of right hemibody, limitation of gait, difficulty for articulating words and deviation of the commissure to the left. In imaging studies, computed tomography of the adrenal glands showed a hypodense image between 8-12 UH compatible with right adrenal adenoma of 12 x 16 x 16 mm.
Conclusion: Although its diagnosis remains a challenge, the importance in the recognition of this disease is that most of the times it allows a specific therapy of surgical and curable type, thus avoiding the deleterious effects of aldosterone in the cardiovascular system and in the beta cells.


REFERENCES

  1. Kline GA, Prebtani AP, Leung AA, Schiffrin EL. Primary aldosteronism: a common cause of resistant hypertension. CMAJ 2017;189(22):E773-E778. doi: 10.1503/cmaj.161486.

  2. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, et al. Laboratory investigation of primary aldosteronism. Clin Biochem Rev 2010;31(2):39.

  3. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006;91(2):454-459. DOI: 10.1210/ jc.2005-1733.

  4. Young DB. Quantitative analysis of aldosterone’s role in potassium regulation. Am J Physiol 1988;255(5):F811-F822. DOI: 10.1152/ajprenal.1988.255.5.F811.

  5. Rossi GP, Bernini G, Caliumi C, Desideri G, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48(11):2293-2300. DOI: 10.1016/j.jacc.2006.07.059.

  6. Funder JW, Carey RM, Mantero F, Murad MH, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101(5):1889-1916. doi: 10.1210/jc.2015-4061.

  7. Azpiroz MB, Calvo M, Hunt MM, Kutasz E, Gutiérrez GA, et al. Rol del laboratorio en el diagnóstico del hiperaldosteronismo primario. Revista Argentina de Endocrinología y Metabolismo 2015;52(4):204-214.

  8. Layden BT, Hahr AJ, Elaraj DM. Primary hyperaldosteronism: challenges in subtype classification. BMC Research Notes 2012;5(1):602.

  9. Vilela LA, Almeida MQ. (2017). Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab 2017;61(3):305-312. doi: 10.1590/2359-3997000000274.

  10. Carvajal CA, Baudrand RF, Fardella CE. Hiperaldosteronismo primario y otras formas de hipertension arterial endocrina. ARS Medica 2016;41(2):42-49. DOI: http://dx.doi. org/10.11565/arsmed.v41i2.386.

  11. Kline G, Holmes DT. Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice. J Clin Pathol 2017 Nov;70(11):911-916. doi: 10.1136/jclinpath- 2017-204423.

  12. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosteroneproducing adrenal adenoma. J Clin Endocrinol Metab 2000;85(12):4526-4533. DOI: 10.1210/jcem.85.12.7086.

  13. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86(3):1066-1071. DOI: 10.1210/jcem.86.3.7282.

  14. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005;16(3):114- 119. DOI: 10.1016/j.tem.2005.02.007.

  15. Lin YC, Lee HY, Juang GD, et al. Technical modification of retroperitoneal laparoscopic adrenalectomy for primary hyperaldosteronism and clinical outcomes. Asian J Surg 2013;36(1):20-25. doi: 10.1016/j.asjsur.2012.08.002.

  16. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertension 2001;19(3):353-361. DOI: 10.1097/00004872-200103000- 00001.

  17. Vaughan ED. Diseases of the adrenal gland. Med Clin 2004;88(2):443-466. DOI: 10.1016/S0025-7125(03)00149- 4.




2020     |     www.medigraphic.com